Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 3
1969 1
1970 1
1971 3
1972 3
1973 2
1974 1
1975 1
1977 1
1978 2
1979 2
1980 1
1981 2
1982 1
1983 4
1984 6
1985 6
1986 7
1987 9
1988 5
1989 9
1990 9
1991 5
1992 7
1993 8
1994 10
1995 8
1996 7
1997 11
1998 7
1999 5
2000 5
2001 11
2002 8
2003 6
2004 7
2005 6
2006 4
2007 4
2008 6
2009 11
2010 4
2011 6
2012 6
2013 9
2014 4
2015 7
2016 7
2017 7
2018 7
2019 2
2020 6
2021 7
2022 12
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
ISH-based HER2 diagnostics.
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: jasani b. Pathologe. 2021 Nov;42(Suppl 1):62-68. doi: 10.1007/s00292-020-00878-6. Epub 2020 Dec 21. Pathologe. 2021. PMID: 33346874 Review. English.
[ISH-based HER2 diagnostics].
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: jasani b. Pathologe. 2020 Nov;41(6):606-613. doi: 10.1007/s00292-020-00841-5. Pathologe. 2020. PMID: 33001242 Review. German.
Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status.
Rüschoff J, Friedrich M, Nagelmeier I, Kirchner M, Andresen LM, Salomon K, Portier B, Sredni ST, Schildhaus HU, Jasani B, Grzelinski M, Viale G. Rüschoff J, et al. Among authors: jasani b. Virchows Arch. 2022 Nov;481(5):685-694. doi: 10.1007/s00428-022-03378-5. Epub 2022 Aug 16. Virchows Arch. 2022. PMID: 35970977 Free PMC article.
Bilirubin-induced neurologic damage.
Hegde D, Jasani B, Mutha S. Hegde D, et al. Among authors: jasani b. N Engl J Med. 2014 Mar 6;370(10):978-9. doi: 10.1056/NEJMc1315973. N Engl J Med. 2014. PMID: 24597882 No abstract available.
In Support of Magnani and Taylor.
Dabbs DJ, Chiriboga LA, Jasani B, Kinloch MA, Miller KD, Nielsen S, Szabolcs MJ, Torlakovic E, Bogen S, Parry S, 't Hart NA. Dabbs DJ, et al. Among authors: jasani b. Arch Pathol Lab Med. 2024 Jan 1;148(1):11. doi: 10.5858/arpa.2023-0446-LE. Arch Pathol Lab Med. 2024. PMID: 38157868 Free article. No abstract available.
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma.
Robert ME, Rüschoff J, Jasani B, Graham RP, Badve SS, Rodriguez-Justo M, Kodach LL, Srivastava A, Wang HL, Tang LH, Troncone G, Rojo F, Van Treeck BJ, Pratt J, Shnitsa I, Kumar G, Karasarides M, Anders RA. Robert ME, et al. Among authors: jasani b. Mod Pathol. 2023 May;36(5):100154. doi: 10.1016/j.modpat.2023.100154. Epub 2023 Mar 15. Mod Pathol. 2023. PMID: 36925069 Free article.
301 results